Another nine drug companies have hopped on board with President Trump's "Most Favored Nation" drug pricing program, bringing the total number of companies participating to 14 of the 17-largest drug manufacturers.
A new report says Elon Musk's efforts to cut "at least" $2 trillion in waste, fraud and abuse did not reduce overall federal spending, but did result in an unmatched peacetime workforce reduction.